All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 97 of 206 pages ‹ First < 95 96 97 98 99 > Last ›
HSL11129
Epstein RA.
Conflicts of interest in health care: who guards the guardians?
Perspect Biol Med 2007 Win;50:(1):72-88
http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v050/50.1epstein.html
HSL11146
Hawkins LC, Edwards JN, Dargan PI.
Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature.
Drug Saf 2007;30:(6):465-79
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17536874&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11184
McCabe C, Tsuchiya A, Claxton K, Raftery J.
Assessing the economic challenges posed by orphan drugs: a comment on Drummond et al.
Int J Technol Assess Health Care 2007 Sum;23:(3):397-401
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=1066128
HSL11185
Hauben M, Reich L, DeMicco J, Kim K.
'Extreme duplication' in the US FDA Adverse Events Reporting System database.
Drug Saf 2007;30:(6):551-4
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17536881&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11244
Golomb BA, McGraw JJ, Evans MA, Dimsdale JE.
Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.
Drug Saf 2007;30:(8):669-75
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17696579&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11250
Downes-Grainger C.
Prescription for Injury: The Politics of Pharmaceutical Manufacture, Regulation and Prescription
2007
http://www.actionminddrugs.org.uk/index2.html
HSL11294
Grinols EL, Henderson JW.
Replace pharmaceutical patents now.
Pharmacoeconomics 2007;25:(5):355-63
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17488135&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11315
Glaeske G.
[The limits of economic efficiency--medication provision and 'border violations' through structures and interests].
Z Arztl Fortbild Qualitatssich 2007;101:(5):347-55
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17711263&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11317
Petros B.
Ethical review of health-related biotechnology research in Africa: a role for the Pan African Bioethics Initiative (PABIN).
Afr J Med Med Sci 2007;36:Suppl:43-7.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17703564&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11349
Pearce N.
Adverse Reactions: The Fenoterol Story
Auckland: Auckland University Press 2007
http://web.archive.org/web/20081231211217/http://www.auckland.ac.nz/uoa/aup/book/2007/fenoterol.cfm
HSL11364
Leeman E.
The costs of compliance.
J Am Acad Psychoanal Dyn Psychiatry 2007 Sum;35:(2):179-87
http://www.atypon-link.com/doi/abs/10.1521/jaap.2007.35.2.179
HSL11376
Berry TR, Wharf-Higgins J, Naylor PJ.
SARS wars: an examination of the quantity and construction of health information in the news media.
Health Commun 2007;21:(1):35-44
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17461750&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11377
Pinkleton BE, Weintraub Austin E, Cohen M, Miller A, Fitzgerald E.
A statewide evaluation of the effectiveness of media literacy training to prevent tobacco use among adolescents.
Health Commun 2007;21:(1):23-34
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17461749&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11454
Almenoff JS.
Innovations for the future of pharmacovigilance.
Drug Saf 2007;30:(7):631-3
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17604419&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11455
Hauben M.
Signal detection in the pharmaceutical industry: integrating clinical and computational approaches.
Drug Saf 2007;30:(7):627-30
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17604418&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11456
Hand DJ.
Principles of data mining.
Drug Saf 2007;30:(7):621-2
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17604416&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11457
Kahn SN.
You've found a safety signal--now what?: regulatory implications of industry signal detection activities
Drug Saf. 2007;30:(7):615-6
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17604414&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11472
Kavadas C, Katsanis LP, Lebel J.
The effects of risk disclosure and ad involvement on consumers in DTC advertising
Journal of Consumer Marketing 2007;24:(3):171-179
HSL11521
Hess V.
[Psychochemicals crossing the wall. The introduction of psychoactive pharmaceuticals in the German Democratic Republic--a perspective from the new historiography of drugs].
Medizinhist J 2007;42:(1):61-84
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17874752
HSL11529
Ferreira G.
Prescription-event monitoring: developments in signal detection.
Drug Saf 2007;30:(7):639-41
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17604421
HSL11541
Globalization, trade and health: pharmaceutical industry
World Health Organization 2007
http://www.who.int/trade/glossary/story073/en/index.html
HSL11550
Dinan W, Miller D.
Thinker, Faker, Spinner, Spy: Corporate PR and the Assault on Democracy
London: Pluto 2007
http://www.amazon.com/Thinker-Faker-Spinner-Spy-Corporate/dp/0745324444/ref=dp_return_1/102-5869202-0212934?ie=UTF8&n=283155&s=books&qid=1190546386&sr=1-1
HSL11551
Miller D, Dinan W.
A Century of Spin
London: Pluto 2007
http://www.amazon.com/Century-Spin-David-Miller/dp/0745326889/ref=sr_1_1/102-5869202-0212934?ie=UTF8&s=books&qid=1190546694&sr=1-1
HSL11609
Solly M.
'Don't get caught out': pragmatic and discourse features of informational and promotional texts in international healthcare insurance.
Commun Med 2007;4:(1):27-35
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17714041
HSL11615
Torbenson M, Erlen J.
A quantitative profile of the patent medicine industry in Baltimore from 1863 to 1930.
Pharm Hist 2007;49:(1):15-27
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17645151
HSL11616
Stakisaitis D, Spokiene I, Juskevicius J, Valuckas KP, Baiardi P.
Access to information supporting availability of medicines for patients suffering from rare diseases looking for possible treatments: the EuOrphan Service.
Medicina (Kaunas) 2007;43:(6):441-6
http://medicina.kmu.lt/0706/0706-01e.pdf
HSL11629
Kauffman JM.
Misleading Recent Papers on Statin Drugs in Peer-Reviewed Medical Journals
Journal of American Physicians and Surgeons Spring 2007;12:(1):7-9
http://www.jpands.org/vol12no1/kauffman.pdf
HSL11780
O'Donovan O.
Corporate Colonization of Health Activism? Irish Health Advocacy Organizations' Modes of Engagement with Pharmaceutical Corporations
Int J Health Serv 2007 Oct;37:(4):711 - 733
http://baywood.metapress.com/openurl.asp?genre=article&id=doi:10.2190/HS.37.4.h
HSL11811
Huberfeld N.
Pharma on the hot seat.
J Health Law 2007 Spr;40:(2):241-65
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17849829
HSL11861
Aggett PJ.
Criteria for substantiating claims.
Novartis Found Symp 2007;282:46-53;:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17913223
HSL11866
Pauwels E
Ethics for Researchers: Facilitating Research Excellence in FP7
Brussels: Governance and Ethics Unit, Science Economy and Society Directorate, European Commission 2007
http://ec.europa.eu/research/science-society/document_library/pdf_06/ethics-for-researchers-040707_en1.pdf
HSL11887
Firmian L, Baudo A.
We'll take care of you
CinemaSalute Srl 2007
http://www.sickpills.com/
HSL11902
Yaros AM.
Attitudes and behaviors of human services students associated with direct-to-consumer advertising (dtca) of prescription drugs.
2007
HSL11919
Olfman S (Ed).
Bipolar Children: Cutting-Edge Controversy, Insights, and Research (Childhood in America)
Westport CT: Praeger Publishers 2007
http://www.praeger.com/catalog/C9730.aspx
HSL11926
Bright RA.
Strategy for surveillance of adverse drug events.
Food Drug Law J 2007;62:(3):605-16
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17915403
HSL11927
Zigler J, Walsh J, Zigler J.
Medical device reporting: issues with Class III medical devices.
Food Drug Law J 2007;62:(3):573-80
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17915398
HSL11928
O'Reilly JT.
Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
Food Drug Law J 2007;62:(3):559-72
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17915397
HSL11929
Tiedt TN.
The drug safety system conundrum.
Food Drug Law J 2007;62:(3):547-558
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17915396
HSL11930
Jacobson JD, Feigal D.
Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.
Food Drug Law J 2007;62:(3):529-46
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17915395
HSL11931
Cobert B.
Drug safety: a contrarian's point of view.
Food Drug Law J 2007;62:(3):501-12
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17915392
HSL11932
Schanz SJ.
Pharmaceutical postmarket review: fact or fiction?
Food Drug Law J 2007;62:(3):493-500
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17915391
HSL11933
Hall RF.
The risk of risk reduction: can postmarket surveillance pose more risk than benefit?
Food Drug Law J 2007;62:(3):473-92
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17915389
HSL11934
Shea LL, Hanson A, Guglielmetti TM, Levy K.
Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases
Food Drug Law J. 2007;62(3):. 2007;62:(3):445-72
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17915388
HSL11937
[No authors listed].
Lilly tuberculosis partnership honoured by global business coalition.
World Hosp Health Serv 2007;43:(2):6-7
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17894186&dopt=AbstractPlus
HSL11944
Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I.
Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
Drug Saf 2007;30:(8):715-26
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17696584
HSL12159
Simpson ID, Norris RL.
Snake antivenom product guidelines in India: "the devil is in the details".
Wilderness Environ Med 2007 Fal;18:(3):163-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17896852
HSL12167
Morgan SE, Harrison TR, Chewning L, Davis L, Dicorcia M.
Entertainment (mis)education: the framing of organ donation in entertainment television.
Health Commun 2007;22:(2):143-51
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17668994
HSL12210
Healy D, Le Noury J.
Pediatric bipolar disorder: An object of study in the creation of an illness
International Journal of Risk & Safety in Medicine 2007;19:(4):209-221
http://iospress.metapress.com/app/home/contribution.asp?referrer=parent&backto=issue,5,9;journal,1,27;linkingpublicationresults,1:103162,1
HSL12221
Drug Pricing and its Regulation in Israel: Issues, Problems and Suggestions For Reform
Israel Drug Bulletin 2007-2008;82:(14):1-18
HSL12233
Bhattacharya D.
An exploration of conceptual and temporal fallacies in international health law and promotion of global public health preparedness.
J Law Med Ethics 2007 Win;35:(4):588-98
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=18076510
HSL12376
Kosińska K, Brandys J.
[Potentially inappropriate drugs for geriatric patients].
Przegl Lek. 2007;64:(1):19-23
http://www.ncbi.nlm.nih.gov/pubmed/18183827?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL12448
Trombetta B.
Category Captain Management: a new approach for healthcare suppliers to partner with their hospital customers.
J Hosp Mark Public Relations 2007;17:(2):61-9
http://www.ncbi.nlm.nih.gov/pubmed/18072705
HSL12494
Darby M.
Debate: a teaching-learning strategy for developing competence in communication and critical thinking.
J Dent Hyg 2007 Fal;81:(4):78
http://www.ncbi.nlm.nih.gov/pubmed/18173892?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL12503
Angelmar R, Angelmar S, Kane L.
Building strong condition brands
Journal of Medical Marketing 2007;7:341-351
http://www.palgrave-journals.com/jmm/journal/v7/n4/full/5050101a.html
HSL12555
Miselli M.
Nimesulide : waiting for Godot
Informazioni sui Farmaci 2007;4:
HSL12597
Kros JF, Nadler S, Molis J.
Customer relationship management in the contract pharmaceutical industry: an exploratory study for measuring success.
Int J Electron Healthc 2007;3:(3):353-66
http://www.ncbi.nlm.nih.gov/pubmed/18048307?dopt=Abstract
HSL12605
Tajanko E, Sein Anand J, Roszkowska-Kranc K, Kozłowska-Boszko B, Chodorowski Z, Korolkiewicz RP.
[Drug counterfeiting--the risk to the public health].
Przegl Lek. 2007;64:(4-5):357-9
http://www.ncbi.nlm.nih.gov/pubmed/17724913?dopt=Abstract
HSL12606
Sein Anand J, Chodorowski Z.
[Side effects after the usage of Chinese dieting product Meizitanc].
Przegl Lek 2007;64:(4-5):346-7
http://www.ncbi.nlm.nih.gov/pubmed/17724909?dopt=Abstract
HSL12607
Wiergowski M, Galer-Tatarowicz K, Nowak-Banasik L, Rutkowska J, Kucułyma G, Waldman W, Chodorowski Z, Jankowski Z, Sein Anand J.
[Hazard for human health and life by unintentional use of synthetic sibutramine, which was sold as Chinese herbal product ]
Przegl Lek 2007;64:(4-5):268-72
http://www.ncbi.nlm.nih.gov/pubmed/17724884?dopt=Abstract
HSL12695
Mintzes B.
A Pill for Every Ill—Or an Ill for Every Pill?
HereToHelp 2007
http://heretohelp.bc.ca/publications/visions/medications/alt/2
HSL12740
McNaughton V.
Black Holes on the Web: Avoiding the Pitfalls of Online Misinformation
Wound Care Canada 2007;5:(2):30-40
http://www.cawc.net/open/wcc/5-2/%20McNaughton-Web.pdf
HSL12797
Lodén M, Ungerth L, Serup J.
Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Acta Derm Venereol 2007;87:(6):485-92
http://adv.medicaljournals.se/article/full/10.2340/00015555-0311
HSL12849
Srivastava RK.
Personal effects? Can emotive marketing through relationships influence rational doctors' prescriptions
Mark Health Serv 2007;27:(4):29-32
http://www.ncbi.nlm.nih.gov/pubmed/18186452?dopt=Abstract
HSL12853
Lopert R, Rosenbaum S.
What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and Australia
J Law Med Ethics 2007;35:(4):643-56, 512-3.
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1748-720X.2007.00187.x
HSL12868
Gehler Mariacher G, Mtasiwa D, Wiedenmayer K, Bruppacher R, Tanner M, Hersberger KE.
In-Kind Drug Donations for Tanzania.
World Health Popul 2007;9:(1):74-99
HSL12922
Murray E, McAdam R.
A comparative analysis of quality management standards for contract research organisations in clinical trials.
Int J Health Care Qual Assur 2007;20:(1):16-33
http://www.ncbi.nlm.nih.gov/pubmed/18240505?dopt=Abstract
HSL12964
Albright JA.
Ethics and constitutional government.
J Long Term Eff Med Implants. 2007;17:(1):35-9
http://www.begellhouse.com/journals/1bef42082d7a0fdf,3df9b2b2057c7c91,247bb83d77ff2761.html
HSL12968
Kosińska K, Brandys J.
[Potentially inappropriate drugs for geriatric patients].
Przegl Lek. 2007;64:(1):19-23
http://www.ncbi.nlm.nih.gov/pubmed/18183827
HSL13000
McKay M.
Forced Drugging of Children in Foster Care: Turning Child Abuse
Journal of Orthomolecular Medicine 2007;22:(2):
http://www.psychrights.org/Kids/2784457McKayForcedDruggingchildren.pdf
HSL13503
Gilhooley M.
Vioxx's history and the need for better procedures and better testing.
Seton Hall Law Rev. 2007;37:(4):941-68
HSL13504
Falit BP.
Curbing industry sponsor's incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield favorable results.
Seton Hall Law Rev. 2007;37:(4):969-1049
HSL13568
Frosch DL, Krueger PM, Hornik RC, Cronholm PF, Barg FK.
Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising.
Ann Fam Med. 2007;5:(1):6-13
HSL13679
Moser HR.
A longitudinal assessment of consumers' attitudes toward physicians' advertising.
J Hosp Mark Public Relations 2007;18:(1):3-19
http://www.ncbi.nlm.nih.gov/pubmed/18453133
HSL13721
Riska E, Heikell T.
Gender and images of heart disease in Scandinavian drug advertising.
Scand J Public Health 2007;35:(6):585-90
http://www.informaworld.com/smpp/content~db=all?content=10.1080/14034940701349233
HSL13742
Iizuka T.
Experts' agency problems: evidence from the prescription drug market in Japan.
Rand J Econ 2007 Aut;38:(3):844-62
http://www.ncbi.nlm.nih.gov/pubmed/18478669
HSL13795
Nishikawa T.
[Profile of Shohei Ninomiya (pharmacist), the first Japanese medical representative to practice modern European-style propaganda in the late Meiji era].
Yakushigaku Zasshi. 2007;42:(2):131-6
http://www.ncbi.nlm.nih.gov/pubmed/18548887
HSL13837
Villafranco JE, Lustigman AB.
Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
Food Drug Law J 2007;62:(4):709-25
http://www.ncbi.nlm.nih.gov/pubmed/18557227
HSL13895
Zain S.
Sword or shield? An overview and competitive analysis of the marketing of 'authorized generics'
Food Drug Law J. 2007;62:(4):739-77.
http://www.ncbi.nlm.nih.gov/pubmed/18557229
HSL13896
Poser S.
Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Food Drug Law J. 2007;62:(4):653-94
http://www.ncbi.nlm.nih.gov/pubmed/18557225
HSL14124
Harrison J.
Notice of failure to disclose financial interest:
Arch Neurol. 2007;64:(9):1323-1329
http://archneur.ama-assn.org/cgi/content/full/65/7/992-a
HSL14772
Khanfar N, Loudon D, Sircar-Ramsewak F.
FDA Direct-to-Consumer Advertising for Prescription Drugs: What Are Consumer Preferences and Response Tendencies?
Health Mark Q. 2007;24:(1/2):77-91
http://www.ncbi.nlm.nih.gov/pubmed/19042521
HSL15270
Grice J.
Global Pharmaceutical Marketing: A practical guide to codes and compliance
London and Chicago: Pharmaceutical Press 2007
http://www.pharmpress.com/shop/product_display.asp?sitelanguage=eng¤cyid=7&productid=9780853697176
HSL15546
Myers SW, Stafford MR.
A profitable new definition of health.
Journal of Consumer Marketing 2007;24:(1):5-7
http://www.emeraldinsight.com/journals.htm?articleid=1590959
HSL15908
Burton B.
Pushing Drugs
Inside Spin : Allen Unwin 2007
http://books.google.com.au/books?id=sBaH8j_Qs-IC&dq=inside+spin+the+dark+underbelly+of+the+pr+industry&printsec=frontcover&source=bn&hl=en&ei=v8RISunTGomWkQXl9MT5CQ&sa=X&oi=book_result&ct=result&resnum=4
HSL16002
Nascimento A.
Propaganda de Medicamentos. É possível regular?
INSTITUTO DE MEDICINA SOCIAL RIO DE JANEIRO: UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO 2007
http://www4.ensp.fiocruz.br/visa/publicacoes/_arquivos/Tese%20Alvaro.pdf
HSL16335
Brownlee S
Overtreated New York: Bloomsbury 2007
http://www.overtreated.com/home.html
HSL16377
Rahmewati F
Nonprescription Drug Promotion in Mass-Media Print Publication in Indonesia
Malaysian Journal of Pharmaceutical Sciences 2007;5:(1):1–6
http://www.doaj.org/doaj?func=abstract&id=541265
HSL16527
Huff-Rousselle M, Simooya O, Kabwe V, Hollander I, Handema R, Mwango A, Mwape E.
Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond.
Glob Public Health. 2007;2:(2):184-203
www.ncbi.nlm.nih.gov/pubmed/19280399
HSL16578
Chen Huijun, Lu Minmin, Wan Xiaoya
Analysis of Psychological Strategies in Chinese TV Medicine Commercials
Asian Social Science 2007;3:(4):
http://www.ccsenet.org/journal/index.php/ass/article/view/3138/0
HSL16923
Nascimento AC
Propaganda de medicamentos. É possível regular?
Instituto de Medicina Social da Universidade do Estado do Rio de Janeiro 2007;286
http://www.ims.uerj.br/ccaps/?p=210
HSL17300
Morgan SG
Direct-to-consumer advertising and expenditures on prescription drugs: a comparison of experiences in the United States and Canada
Open Medicine 2007;1:(1):
http://www.openmedicine.ca/article/viewArticle/23/26
HSL17353
Vanderveer RB, Pines NM
Customer-Driven Positioning: The next generation approach to pharmaceutical product positioning
Journal of Medical Marketing 2007;7:(1):71–76
http://www.palgrave-journals.com/jmm/journal/v7/n1/abs/5050066a.html
HSL18355
Trombetta B
Category captain management: an idea whose time has come in the pharmaceutical industry?
International Journal of Pharmaceutical and Healthcare Marketing 2007;4:(2):157 - 174
http://www.emeraldinsight.com/journals.htm?articleid=1865336
HSL7031
GAO .
Prescription Drugs : Improvements needed in FDA's Oversight of Direct-to-Consumer Advertising
United States Government Accountability Office ( GAO) 2006 Nov 31
http://www.gao.gov/new.items/d0754.pdf
HSL7388
Abelson R.
The Spine as Profit Center
The New York Times 2006 Dec 30
http://select.nytimes.com/gst/abstract.html?res=F3081EFC3D540C738FDDAB0994DE404482
HSL7496
Rosenberg M.
New Year's Resolutions for Big Pharma
CommonDreams.org 2006 Dec 30
http://www.commondreams.org/cgi-bin/print.cgi?file=/views06/1230-23.htm
HSL7364
Witkowski W.
Pharma Consolidation to Continue in 2007
Associated Press 2006 Dec 29
http://www.forbes.com/technology/sciences/feeds/ap/2006/12/29/ap3288175.html
HSL7533
Canadian pharmacists push for power to prescribe
CTV.ca 2006 Dec 29
http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20061229/pharm_pills_061229/20061229?hub=Health
HSL7358
Jirik K.
How Great Researchers Get By-lines, Get Paid, and Get Medicine in Trouble
Bioethics Forum 2006 Dec 28;
http://www.bioethicsforum.org/plagiarism-in-medical-research.asp
HSL7361
Waters R.
J&J Sued by Texas in Whistleblower Case on Marketing (Update1)
Bloomberg.com 2006 Dec 28
http://www.bloomberg.com/apps/news?pid=20601202&sid=a2mpCNBojB2I&refer=healthcare
Page 97 of 206 pages ‹ First < 95 96 97 98 99 > Last ›
